Michael has over 15 years of experience in healthcare investment research and asset management.

He is an advisor to HBM Partners, a leading healthcare focused investment fund, and is responsible for identifying investment opportunities. Previously, Michael was the biotech analyst for Traxis Partners, Sivik Global Healthcare and Jefferies Asset Management.

Michael has also been founder of several development stage biotech companies and presently serves on 4 company boards. Michael received a Master’s degree in Medical Science from MCP/Hahnemann School of Medicine and has worked in R&D for SmithKline Beecham Pharmaceuticals.